• Strategic planning, project management and self-motivation in all aspects of research, from idea conception to experimentation, characterization, documentation, and write-up, leading to the accomplishment of project goal and publication• Regulate daily operation of a research laboratory, including maintaining equipment and supplies, updating chemical hygiene plan, writing and maintenance of specific standard operating procedures (SOP), and ensuring adherence to safety protocols• Developed and optimized metabolic imaging platform to demonstrate novel metabolic inhibitors as radiation modifier in collaboration with NCATS and NCI Experimental Therapeutics (NExT) program.• Currently leading cross functional team to demonstrate novel K-ras G12C inhibitors in combination therapy in non-small cell lung cancer • Designed projects for and mentored a post-baccalaureate student• Demonstrated oral communications skills by delivering 2 invited talks at the scientific conferences

• Read various articles for their content and correct spelling, punctuation, and grammatical errors• Rewrite the text to make it easier for readers to understand• Verify facts cited in material for publication• Contributed articles on public speaking skills of scientists, meeting reports, conference experience, and informational interview series highlighting non-traditional career paths for postdocs in the quarterly CCR-FYI Newsletter

• Served as an Entrepreneurial lead and worked in a 3 member team comprising of a postdoctoral fellow, NCI technology transfer fellow and NCI technology transfer manager and conducted due diligence and market feasibility analysis for an early- stage NCI technology• Applied the industry mentored program tools and conducted 30+ interviews with physicians, patients, nurses, startup CEOs, Investors, disease foundations, subject matter experts to understand the opportunities and challenges associated with the technology commercialization process • Built relationships with potential customers and developed Sales strategy & Revenue model, identified Market size, Regulatory considerations, Reimbursement Strategy, Business model canvas for the technology• Presented the business model canvas and workflow to the program coordinator and provided creative feedback to the inventor about the gaps and potential opportunities for future marketing of the technology

• Coordinated activities between NCI and CTEP to procure, plan, execute, and analyzed data to demonstrate AT13387 (HSP-90 inhibitor) as a novel radiation modifier in head and neck cancer leading to publication in a reputed peer reviewed journal• Reviewed, written and edited an invited book chapter on “Biological application of Nitroxides” published by Royal Society of Chemistry

• Participated in Technology Transfer (TT) Bootcamp geared to build a knowledge base on principles of technology transfer, invention identification disclosure, patent, portfolio, and marketing analysis on early-stage biomedical innovation • Reviewed and edited technology abstract for NCI TT website, drafted employee invention report• performed 10+ NCI technology triage analyses for disease indication, target, and market competition• Developed relationship with NCI inventor and helped educate about the technology transfer process, attended one on meeting with the inventor and developed strategy for building an external partnership for revenue generation and technology commercialization• Identified potential stakeholders for marketing and collaborations/partnership efforts for CRADA and licensing opportunities• Developed marketing strategy of technology, reached out to the prospective partners, drafted emails tracked and managed the progress of the project, timely communicated the marketing leads with the technology transfer managers• Conducted technology feasibility analysis, competitive landscape, and market size analysis for a given technology and drafted findings in a report• Prepared 3 technology elevator pitches and presented the technology at the NCI technology showcase to various stakeholders in the Maryland region

• Developed, managed, and conducted multiple independent and collaborative pre-clinical research projects including but not limited to investigating Abemaciclib (CDK4/6 inhibitor) as radiation modifiers, TH-302 as hypoxia sensitizer, and molecular imaging studies to evaluate pharmacological actions of novel anti-cancer drug SQAP (LAVURCHIN, licensed by Malignant Tumor Treatment Technologies, (MT3) Inc.) on tumor microenvironment• Analyzed tumor immune microenvironment interactions post-radiotherapy, biomarkers identification in vitro and in vivo using an orthotopic xenograft model• Conducted large metabolomic data set analysis to identify key metabolic pathways involved in drug action, therapeutic targets for DNA damage response, and repair in vitro and in vivo• Monitored developments in relevant fields and advised senior staff and colleagues on recent findings• Established novel methods, standard operating procedures, and quality control mechanisms for in vitro and in vivo experiment• Presented research findings in scientific meetings and conferences as posters and invited talks• Led and managed the Department’s metabolism experiment and seahorse unit• Monitored, troubleshooting, and interpretation of research progress

Provided scientific guidance in the MBA course ‘Discovery to Market’ at the Johns Hopkins Carey Business School